Kim M - Search Results

1

Bio-mitigation of CO₂: The co-production of phycocyanin and optically pure (R)-γ-valerolactone with perfect enantiomeric excess.

Cha J, Choi Y, Sung C, Kim M, Park WK, Min K. Cha J, et al. Among authors: kim m. Bioresour Technol. 2024 Nov 28;418:131895. doi: 10.1016/j.biortech.2024.131895. Online ahead of print. Bioresour Technol. 2024. PMID: 39612958

2

Simple visualization method for the c.577del of erythropoietin variant: CRISPR/dCas9-based single nucleotide polymorphism diagnosis.

Yi JY, Kim M, Jeon M, Min H, Kim BG, Son J, Sung C. Yi JY, et al. Among authors: kim bg, kim m. Drug Test Anal. 2024 Aug;16(8):786-791. doi: 10.1002/dta.3438. Epub 2023 Jan 15. Drug Test Anal. 2024. PMID: 36610033

3

CRISPR/deadCas9-based high-throughput gene doping analysis (HiGDA): A proof of concept for exogenous human erythropoietin gene doping detection.

Yi JY, Kim M, Ahn JH, Kim BG, Son J, Sung C. Yi JY, et al. Among authors: kim bg, kim m. Talanta. 2023 Jun 1;258:124455. doi: 10.1016/j.talanta.2023.124455. Epub 2023 Mar 15. Talanta. 2023. PMID: 36933297 Free article.

4

One-step detection of procollagen type III N-terminal peptide as a fibrosis biomarker using fluorescent immunosensor (quenchbody).

Yi JY, Ryu J, Jeong Y, Cho Y, Kim M, Jeon M, Park HH, Hwang NS, Jeong HJ, Sung C. Yi JY, et al. Among authors: kim m. Anal Chim Acta. 2024 Aug 15;1317:342887. doi: 10.1016/j.aca.2024.342887. Epub 2024 Jun 18. Anal Chim Acta. 2024. PMID: 39030019 Free article.

5

Production and engineering of nanobody-based quenchbody sensors for detecting recombinant human growth hormone and its isoforms.

Jung J, Jeong Y, Xu Y, Yi J, Kim M, Jeong HJ, Shin SH, Yang YH, Son J, Sung C. Jung J, et al. Among authors: kim m. Drug Test Anal. 2023 Nov-Dec;15(11-12):1439-1448. doi: 10.1002/dta.3562. Epub 2023 Sep 4. Drug Test Anal. 2023. PMID: 37667448

6

The Synergistic Effect of PARP Inhibitors and Irinotecan in Small Cell Lung Cancer Cells.

Oh S, Kim S, Keam B, Youk J, Kim TM, Kim DW, Kim M. Oh S, et al. Among authors: kim m. Cancer Res Treat. 2025 Jan 7. doi: 10.4143/crt.2024.728. Online ahead of print. Cancer Res Treat. 2025. PMID: 39788642

7

New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: a nationwide population-based cohort study.

Cho YK, Kim S, Kim MJ, Lee WJ, Kim YJ, Jung CH. Cho YK, et al. Among authors: kim mj. Diabetes Metab. 2025 Jan 7:101605. doi: 10.1016/j.diabet.2025.101605. Online ahead of print. Diabetes Metab. 2025. PMID: 39788347

8

Utilization of Acid Suppressants After Withdrawal of Ranitidine in Korea: An Interrupted Time Series Analysis.

Choi JP, Kim S, Park JS, Kim MS, Choi NK, Shin CM, Lee J. Choi JP, et al. Among authors: kim ms. J Prev Med Public Health. 2024 Dec 30. doi: 10.3961/jpmph.24.357. Online ahead of print. J Prev Med Public Health. 2024. PMID: 39788691

9

Biomarkers.

Park JS, Park H, Cho MH, Hwang KH, Kim MS. Park JS, et al. Among authors: kim ms. Alzheimers Dement. 2024 Dec;20 Suppl 2:e088529. doi: 10.1002/alz.088529. Alzheimers Dement. 2024. PMID: 39786050

10

Public Health.

Ihara K, Opsasnick L, Bonham M, Batio S, Yoshino-Benavente J, Curtis LM, Bailey SC, Wolf MS, Kim M. Ihara K, et al. Among authors: kim m. Alzheimers Dement. 2024 Dec;20 Suppl 7:e088947. doi: 10.1002/alz.088947. Alzheimers Dement. 2024. PMID: 39785192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,857 results

Search Page

Filters